Crompton Greaves: Margin Recovery Sparks Analyst Upgrades

⚡

impressed with a 30% YoY jump in Q4 EBITDA and 23% rise in net profit, backed by 5% revenue growth. Jefferies maintains a 'Buy' with a ₹485 target, while CLSA upgrades to ₹410, citing strong margin recovery, premiumisation, and product innovation as key growth drivers.